Загрузка...
Long-term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients with Centrally Located Thoracic Tumors
BACKGROUND: Stereotactic ablative radiotherapy (SABR) is effective for thoracic cancer and metastases; however, adverse effects are greater for central tumors. We evaluated factors affecting outcomes and toxicities after SABR for patients with primary lung and oligometastatic tumors. PATIENTS AND ME...
Сохранить в:
| Опубликовано в: : | Radiol Oncol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Sciendo
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7585334/ https://ncbi.nlm.nih.gov/pubmed/32589607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2020-0039 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|